Navigation Links
Star Scientific Files Annual Financial Report With SEC, Regains Compliance With NASDAQ Minimum Bid-Price Requirement
Date:3/16/2010

GLEN ALLEN, Va., March 16 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) filed its annual report on Form 10-K today with the Securities and Exchange Commission. The company reported net sales of $0.7 millions for 2009 compared to $0.5 million in total sales for the previous year.  Cash and cash equivalents at year-end 2009 totaled $12.4 million compared with $6.5 million at year-end 2008. The net loss for 2009 totaled approximately $(22.8) million compared to a net loss of $(18.3) million for 2008.  The increase in net loss between 2008 and 2009 was due in part to $3.8 million in costs associated with the jury trial of Star's patent infringement lawsuit against RJ Reynolds as well as to research expenditures of roughly $1.8 million during 2009, compared to $0.3 million during 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090317/STARSCIENTIFICLOGO )  

Resources allocated to research in 2009 were directed primarily to development and premarket  analyses of CigRx™ by the company's Rock Creek Pharmaceuticals' subsidiary.  CigRx™, which contains neither tobacco nor nicotine, is expected to enter a test market during 2010. The product is directed to adult smokers for use in temporarily reducing the desire to smoke.  Star also expended roughly $0.4 million on research and development work in the area of formulation for its dissolvable smokeless tobacco products, Ariva® and Stonewall®.  A targeted marketing and sales initiative, similar to the 2008 efforts for Stonewall Hard Snuff®, is underway to expand the retail presence of Ariva®.  The current effort will be ongoing through third-quarter 2010.  In addition, as the company reported in February, Star has submitted an application to the FDA for approval to market Ariva-BDL™ as a modified-risk tobacco product under the agency's new tobacco regulations.

The company also reported that after the close of trading on March 16 it received a letter from NASDAQ indicating that Star now has regained compliance with the NASDAQ minimum bid-price listing requirement. The company's stock has maintained a closing bid price above $1.00 for ten consecutive trading days, as required by the NASDAQ listing rules.

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = =  

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Star Scientific, Inc. and its consolidated subsidiaries (collectively, the "Company") has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates", "believes", "estimates", "expects", "plans", "intends" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it.  Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in, or implied by, such statements. These risks, uncertainties and contingencies include, without limitation, the challenges inherent in new product development initiatives, the uncertainties inherent in the progress of scientific research, the Company's ability to raise additional capital in the future necessary to maintain its business, potential disputes concerning the Company's intellectual property, risks associated with litigation regarding such intellectual property, potential delays in obtaining any necessary government approvals of the Company's low-TSNA tobacco products, market acceptance of the Company's new smokeless tobacco products, competition from companies with greater resources than the Company, the Company's decision not to join the Master Settlement Agreement ("MSA"), and the Company's dependence on key employees and on its strategic relationships with Brown & Williamson Tobacco Corporation in light of its combination with RJ Reynolds Tobacco Company, Inc.  

Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that the expectations will be attained or that any deviation will not be material. See additional discussion under "Risk Factors" in the Company's Annual Report on Form 10-K as filed with the SEC on March 16, 2010, and other factors detailed from time to time in the Company's other filings with the SEC, available at www.sec.gov. All information in this release is current as of this date, and the Company undertakes no obligation to update or advise upon any such forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.  

About Star Scientific

Star Scientific is a technology-oriented company with a mission to reduce the harm associated with tobacco at every level. It is engaged in the development of dissolvable smokeless tobacco products that deliver fewer carcinogenic toxins, principally through the utilization of the innovative StarCured® tobacco curing technology.  Through its Rock Creek Pharmaceuticals subsidiary it is also involved in the development of nutraceuticals as well as products to address neurological and mood disorders. Star Scientific has a Corporate and Sales Office in Glen Allen, VA, an Executive, Scientific & Regulatory Affairs office in Bethesda, MD, and a manufacturing facility in Chase City, VA.  Rock Creek has scientific and research offices in Gloucester, MA and a regulatory office in Washington, D.C.

See Star's website at: http://www.starscientific.com

    
    
    Contact:  
    Sara Troy Machir
    Vice President, Communications & Investor Relations
    smachir@starscientific.com
    (301) 654-8300

SOURCE Star Scientific, Inc.

Back to top

RELATED LINKS
http://www.starscientific.com

'/>"/>

SOURCE Star Scientific, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Fifty years of the light fantastic: Laser advances spark scientific progress
2. 100 Day Countdown to the World Congress of Cardiology Scientific Sessions 2010
3. Scientific community to set research agenda for infection prevention and control for next decade
4. FDA Appoints Highly Qualified Scientific Experts to Tobacco Products Scientific Advisory Committee
5. Neutrons poised to play big role in future scientific advances
6. New Scientific Studies Show Further Evidence of Avandia Dangers
7. Genetix Pharmaceuticals' Adrenoleukodystrophy (ALD) Product Recognized As One of Science Magazine's Top 10 Scientific Breakthroughs of 2009
8. The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer
9. American Scientific Resources 2009 Annual Meeting of Shareholders Adjourned
10. American Scientific CE Removed - Now Current Information
11. Lung Cancer Foundation of America Gives the Gift of Life This Holiday Season: Announces Inaugural $125,000 Scientific Research Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 16, 2017 , ... Houston ... Center, is currently offering complimentary consultations and financing for orthodontics for a limited ... bite irregularities and learn about their orthodontic options. Walk-in, late-evening, Saturday, and same-day ...
(Date:1/16/2017)... MO (PRWEB) , ... January 16, 2017 , ... St. Louisans are well-aware of the ... , This year’s influenza shot seems to be having no effect on keeping ... at least half of the people around are coughing, sneezing, or sniffling ...
(Date:1/16/2017)... ... , ... San Francisco dentist, Dr. Ben Amini , the founder at ... is capable of taking digital impressions of teeth and gums. Conventional bite impressions have ... restorations , in terms of speed, efficiency and patient comfort. Increasingly, digital impressions are ...
(Date:1/15/2017)... ... 15, 2017 , ... Whole Health Supply, LLC is announcing the release of an updated version ... for purchase. , The 2017 edition has wide jaws that will accommodate nails up ... as well as diabetics. This handle is reinforced for extra strength when pressing down on ...
(Date:1/15/2017)... ... January 15, 2017 , ... The Gravity Vault Indoor Rock Climbing Gym is ... wraps up on the 14,000+ square foot climbing gym, the owners anticipate to open ... in New Jersey and two in New York. With this being its first location ...
Breaking Medicine News(10 mins):
(Date:1/14/2017)... , Jan. 14, 2017  Johnson & Weaver, LLP ... of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ... through October 31, 2016 (the "Class Period"). Zimmer ... and markets orthopaedic reconstructive products, such as knee and hip ... ...
(Date:1/13/2017)... Eli Lilly and Company (NYSE: ... ) announced today that the U.S. Food and Drug ... new drug application (NDA) for investigational baricitinib, a once-daily ... rheumatoid arthritis (RA). The NDA for baricitinib was submitted ... FDA extended the action date to allow time to ...
(Date:1/13/2017)... New York , January 13, 2017 ... rising prevalence of AIDS will collectively contribute to the demand ... expected to reach a value of US$ 551.0 Mn by ... will remain the most lucrative markets for western blotting, ... lead the market globally. ...
Breaking Medicine Technology: